Literature DB >> 21659520

Phosphorylation directly regulates the intrinsic DNA cytidine deaminase activity of activation-induced deaminase and APOBEC3G protein.

Zachary L Demorest1, Ming Li, Reuben S Harris.   

Abstract

The beneficial effects of DNA cytidine deamination by activation-induced deaminase (AID; antibody gene diversification) and APOBEC3G (retrovirus restriction) are tempered by probable contributions to carcinogenesis. Multiple regulatory mechanisms serve to minimize this detrimental outcome. Here, we show that phosphorylation of a conserved threonine attenuates the intrinsic activity of activation-induced deaminase (Thr-27) and APOBEC3G (Thr-218). Phospho-null alanine mutants maintain intrinsic DNA deaminase activity, whereas phospho-mimetic glutamate mutants are inactive. The phospho-mimetic variants fail to mediate isotype switching in activated mouse splenic B lymphocytes or suppress HIV-1 replication in human T cells. Our data combine to suggest a model in which this critical threonine acts as a phospho-switch that fine-tunes the adaptive and innate immune responses and helps protect mammalian genomic DNA from procarcinogenic lesions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21659520      PMCID: PMC3143621          DOI: 10.1074/jbc.M111.235721

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation.

Authors:  Kevin M McBride; Anna Gazumyan; Eileen M Woo; Vasco M Barreto; Davide F Robbiani; Brian T Chait; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-24       Impact factor: 11.205

2.  A curated compendium of phosphorylation motifs.

Authors:  Ramars Amanchy; Balamurugan Periaswamy; Suresh Mathivanan; Raghunath Reddy; Sudhir Gopal Tattikota; Akhilesh Pandey
Journal:  Nat Biotechnol       Date:  2007-03       Impact factor: 54.908

3.  Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect.

Authors:  Yasumasa Iwatani; Hiroaki Takeuchi; Klaus Strebel; Judith G Levin
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism.

Authors:  Mark D Stenglein; Reuben S Harris
Journal:  J Biol Chem       Date:  2006-04-28       Impact factor: 5.157

5.  The APOBEC-2 crystal structure and functional implications for the deaminase AID.

Authors:  Courtney Prochnow; Ronda Bransteitter; Michael G Klein; Myron F Goodman; Xiaojiang S Chen
Journal:  Nature       Date:  2006-12-24       Impact factor: 49.962

6.  PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells.

Authors:  Laura Pasqualucci; Yasuyuki Kitaura; Hua Gu; Riccardo Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-30       Impact factor: 11.205

7.  Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells.

Authors:  M Muramatsu; V S Sankaranand; S Anant; M Sugai; K Kinoshita; N O Davidson; T Honjo
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

8.  A new reporter cell line to monitor HIV infection and drug susceptibility in vitro.

Authors:  A Gervaix; D West; L M Leoni; D D Richman; F Wong-Staal; J Corbeil
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

Review 9.  Molecular mechanisms of antibody somatic hypermutation.

Authors:  Javier M Di Noia; Michael S Neuberger
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

10.  MDM2 can interact with the C-terminus of AID but it is inessential for antibody diversification in DT40 B cells.

Authors:  Donna A MacDuff; Michael S Neuberger; Reuben S Harris
Journal:  Mol Immunol       Date:  2005-08-24       Impact factor: 4.407

View more
  24 in total

1.  Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.

Authors:  Zhigang Chen; Thomas L Eggerman; Alexander V Bocharov; Irina N Baranova; Tatyana G Vishnyakova; Roger Kurlander; Amy P Patterson
Journal:  J Biol Chem       Date:  2017-06-21       Impact factor: 5.157

Review 2.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

3.  Biochemical and biological studies of mouse APOBEC3.

Authors:  Smita Nair; Silvia Sanchez-Martinez; Xinhua Ji; Alan Rein
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

4.  The first crystal structure of a dTTP-bound deoxycytidylate deaminase validates and details the allosteric-inhibitor binding site.

Authors:  Ailie Marx; Akram Alian
Journal:  J Biol Chem       Date:  2014-11-17       Impact factor: 5.157

5.  APOBEC3B and AID have similar nuclear import mechanisms.

Authors:  Lela Lackey; Zachary L Demorest; Allison M Land; Judd F Hultquist; William L Brown; Reuben S Harris
Journal:  J Mol Biol       Date:  2012-03-23       Impact factor: 5.469

6.  Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination.

Authors:  Lela Lackey; Emily K Law; William L Brown; Reuben S Harris
Journal:  Cell Cycle       Date:  2013-02-06       Impact factor: 4.534

Review 7.  Regulation of immunoglobulin class-switch recombination: choreography of noncoding transcription, targeted DNA deamination, and long-range DNA repair.

Authors:  Allysia J Matthews; Simin Zheng; Lauren J DiMenna; Jayanta Chaudhuri
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

8.  First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G.

Authors:  Ming Li; Shivender M D Shandilya; Michael A Carpenter; Anurag Rathore; William L Brown; Angela L Perkins; Daniel A Harki; Jonathan Solberg; Derek J Hook; Krishan K Pandey; Michael A Parniak; Jeffrey R Johnson; Nevan J Krogan; Mohan Somasundaran; Akbar Ali; Celia A Schiffer; Reuben S Harris
Journal:  ACS Chem Biol       Date:  2012-01-17       Impact factor: 5.100

9.  IFN-α treatment inhibits acute Friend retrovirus replication primarily through the antiviral effector molecule Apobec3.

Authors:  Michael S Harper; Bradley S Barrett; Diana S Smith; Sam X Li; Kathrin Gibbert; Ulf Dittmer; Kim J Hasenkrug; Mario L Santiago
Journal:  J Immunol       Date:  2013-01-11       Impact factor: 5.422

10.  APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.

Authors:  Jinhui Li; Yan Chen; Ming Li; Michael A Carpenter; Rebecca M McDougle; Elizabeth M Luengas; Patrick J Macdonald; Reuben S Harris; Joachim D Mueller
Journal:  J Mol Biol       Date:  2013-12-17       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.